Xuemei Yao
Chongqing, 400044, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Radiation-triggerable bioreactors enable bioenergetic reprograming of cancer stem cell plasticity via targeted arginine metabolism disruption for augmented radio-immunotherapy.
Journal: Biomaterials
Published: January 23, 2025
Optically controllable nanoregulators enable tumor-specific pro-ferroptosis lipometabolic reprogramming for in-situ adjuvant-free vaccination.
Journal: Biomaterials
Published: October 29, 2024
Nanointegrative Glycoengineering-Activated Necroptosis of Triple Negative Breast Cancer Stem Cells Enables Self-Amplifiable Immunotherapy for Systemic Tumor Rejection.
Journal: Advanced healthcare materials
Published: October 03, 2023
Programmable melanoma-targeted radio-immunotherapy via fusogenic liposomes functionalized with multivariate-gated aptamer assemblies.
Journal: Nature communications
Published: July 12, 2023
Inhibition of glycolysis-driven immunosuppression with a nano-assembly enhances response to immune checkpoint blockade therapy in triple negative breast cancer.
Journal: Nature communications
Published: April 23, 2023
Mechanotransduction in response to ECM stiffening impairs cGAS immune signaling in tumor cells.
Journal: Cell reports
Published: April 01, 2023
Injectable microenvironment-responsive hydrogels with redox-activatable supramolecular prodrugs mediate ferroptosis-immunotherapy for postoperative tumor treatment.
Journal: Acta biomaterialia
Published: March 25, 2023
Coordination-driven FBXW7 DNAzyme-Fe nanoassembly enables a binary switch of breast cancer cell cycle checkpoint responses for enhanced ferroptosis-radiotherapy.
Journal: Acta biomaterialia
Published: March 02, 2023
Modulating tumor physical microenvironment for fueling CAR-T cell therapy.
Journal: Advanced drug delivery reviews
Published: January 04, 2022
YTHDF1 upregulation mediates hypoxia-dependent breast cancer growth and metastasis through regulating PKM2 to affect glycolysis.
Journal: Cell death & disease
Published: October 13, 2021
An ROS-Activatable Nanoassembly Remodulates Tumor Cell Metabolism for Enhanced Ferroptosis Therapy.
Journal: Advanced healthcare materials
Published: August 18, 2021
Last Updated: 09/26/2026